脑脊液分流技术六十年专利文献计量分析
该研究对Lens数据库764项脑脊液分流相关授权专利进行回顾性文献计量分析,以引用量和引用速度衡量技术影响力。前100项高被引专利中导管/引流硬件和压力调节技术占82%,监测传感技术仅占9%但引用速度中位数最高(6.3次/年),提示创新正从传统分流架构向生理监测与自适应调控转移。
要点
- 导管与阀门迭代仍是主流创新,占前100项高被引专利的82%。
- 监测传感专利占比仅9%,但引用速度中位数达6.3次/年,为新兴方向。
- 专利活动整体呈指数增长,1980年代末和2020年代初出现明显高峰。
核心结论
- 脑脊液分流相关专利活动随时间大幅增加,有影响力的创新仍集中于导管和阀门系统的迭代改进。
- 监测与传感技术虽专利占比低,但引用速度最高,提示技术发展正超越传统分流架构。
- 未来进展取决于将生理监测、自适应流量调节和实时反馈整合进下一代分流平台。
研究设计与样本
- 回顾性专利文献计量分析,使用Lens数据库。
- 通过关键词检索和合作专利分类(CPC)限制检索脑脊液分流相关授权专利。
- 共识别764项专利,按原始前向引用次数和引用速度排序,审核前100项高被引专利并按主要技术创新分类。
主要发现
- 共识别764项脑脊液分流相关专利,整体专利活动呈指数增长,1980年代末和2020年代初出现明显激增。
- 前100项最具影响力专利中,导管/引流硬件和压力调节技术合计占82%。
- 监测和传感技术仅占前100项专利的9%,但引用速度中位数最高,为6.3次/年。
关键数值与推荐
- 以原始前向引用次数和引用速度作为技术影响力的替代指标。
- 前100项高被引专利中导管/引流硬件与压力调节技术占82%,监测与传感技术占9%。
- 监测与传感技术引用速度中位数为6.3次/年。
临床怎么用
- 关注监测与传感、自适应流量调节和实时反馈作为下一代分流平台的可能方向。
- 传统导管与阀门系统仍是当前高影响力创新的主要载体。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite decades of technological development, cerebrospinal fluid (CSF) shunts remain associated with high failure rates and limited structural evolution. While bibliometric analyses have characterized innovation trends across several neurosurgical subspecialties, no dedicated patent analysis of CSF shunt technology exists. This study characterized the evolution of CSF shunt-related intellectual property (IP) and identified features associated with influential innovation. METHODS: A retrospective patent bibliometric analysis was performed using the Lens database. Granted patents related to CSF shunt technology were identified using keyword-based and Cooperative Patent Classification (CPC)-restricted searches. Patents were ranked by raw forward citation count and citation velocity as surrogate markers of technological influence. The 100 most highly cited patents were reviewed and categorized by primary technological innovation. RESULTS: A total of 764 CSF shunt-related patents were identified. Overall patent activity demonstrated exponential growth over time, with notable surges during the late 1980s and early 2020s. Among the 100 most influential patents, catheter/drainage hardware and pressure-regulation technologies accounted for 82% of patents. In contrast, monitoring and sensing technologies represented only 9% of patents but demonstrated the highest median citation velocity at 6.3 citations per year. CONCLUSIONS: CSF shunt-related patent activity has increased substantially over time. While influential innovation remains concentrated in iterative refinements of catheter and valve systems, citation velocity identified monitoring and sensing as an emerging area of technological influence, highlighting recent shifts in technological development beyond traditional shunt architectures. Future progress will depend on integrating physiologic monitoring, adaptive flow regulation, and real-time feedback into next-generation shunt platforms.
引用
- Hainline M, Botterbush KS, Patel M, et al. The Evolution of Technological Innovation in CSF Shunt Technology: A Patent Bibliometric Analysis Encompassing the Past 60 Years. World Neurosurg. 2026. PMID: 42880705. doi:10.1016/j.wneu.2026.125430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。